Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 7/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL624421 | 0.80 | CHRNB2 (0.35) | CHRNB2CHRNA7CHRNA4LMNA | |
| Bromide SCHEMBL8075410 | 0.79 | CHRNB2 (0.34) | CHRNB2CHRNA7CHRNA4LMNA | |
| SCHEMBL28326210 | 0.71 | SLC6A12 (0.41) | — | |
| SCHEMBL963370 | 0.69 | GABRR1 (0.35) | GABRR1CHRNB2CHRNA7CHRNA4CRHBP | |
| SCHEMBL26805245 | 0.68 | ABAT (0.36) | LMNATSHR | |
| SCHEMBL15158296 | 0.67 | CCR2 (0.38) | CCR2GABRR1 | |
| SCHEMBL6844884 | 0.65 | OPRD1 (0.46) | — | |
| SCHEMBL27545542 | 0.65 | CHRNB2 (0.33) | CHRNB2CHRNA7CHRNA4LMNA | |
| SCHEMBL17017266 | 0.65 | CHRNB2 (0.44) | CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL15857970 | 0.64 | GABRR1 (0.55) | CCR2GABRR1LMNACES2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190185797-A1 | OPEN LOOP ADDITIVE MATERIAL PROCESS AND SYSTEM FOR CREATING A HUMAN-HABITABLE ENVIRONMENT | DIY Service LLC (US) | 2019-06-20 | — | — | US | claimed |
| WO-2019118887-A1 | OPEN LOOP ADDITIVE MATERIAL PROCESS AND SYSTEM FOR CREATING A HUMAN-HABITABLE ENVIRONMENT | DIY Service LLC (US) | 2019-06-20 | — | — | WO | claimed |
| US-10323156-B2 | Method of three-dimensional printing | XEROX CORPORATION (US) | 2019-06-18 | — | — | US | claimed |
| US-20170327704-A1 | SUSTAINABLE MATERIALS FOR THREE-DIMENSIONAL PRINTING | Genesee Valley Innovations, LLC | 2017-11-16 | — | — | US | claimed |
| US-20170051168-A1 | SUSTAINABLE MATERIALS FOR THREE-DIMENSIONAL PRINTING | Genesee Valley Innovations, LLC | 2017-02-23 | — | — | US | claimed |
| US-20160130451-A1 | SUSTAINABLE MATERIALS FOR THREE-DIMENSIONAL PRINTING | XEROX CORPORATION | 2016-05-12 | — | — | US | claimed |
| US-10900004-B2 | Open loop additive material process and system for creating a human-habitable environment | DIY Service LLC (US) | 2021-01-26 | — | — | US | disclosed |
| US-10799610-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2020-10-13 | — | — | US | disclosed |
| US-10711146-B2 | Method of three-dimensional printing | XEROX CORPORATION (US) | 2020-07-14 | — | — | US | disclosed |
| EP-3243658-B1 | 3-D PRINTING USING INTERMEDIATE TRANSFER BELT AND CURABLE POLYMERS | XEROX CORP (US) | 2020-07-08 | — | — | EP | disclosed |
| CN-110343038-A | A kind of treasured Rogor monomer, extract and its preparation method and application | 暨南大学 | 2019-10-18 | — | — | CN | disclosed |
| US-10413632-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| US-10350828-B2 | 3-D printing using intermediate transfer belt and curable polymers | XEROX CORPORATION (US) | 2019-07-16 | — | — | US | disclosed |
| US-20090270527-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | ANGSTROM MEDICA (US) | 2009-10-29 | — | — | US | disclosed |
| EP-2083760-A2 | FUSION DEVICE, SYSTEMS AND METHODS THEREOF | Pioneer Surgical Technology, Inc. (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2009029734-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2008140551-A2 | FUSION DEVICE | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2008-11-20 | — | — | WO | disclosed |
| EP-1922052-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | Angstrom Medica, Inc. (US) | 2008-05-21 | — | — | EP | disclosed |
| WO-2007019461-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | ANGSTROM MEDICA, INC. (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070032568-A1 | Cement products and methods of making and using the same | ANGSTROM MEDICA (US) | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032568-A1 | Cement products and methods of making and using the same | BMP2, ETF1, EPHX2 | CCR2 2607/4885GABRR1 1732/4885CHRNB2 3025/4885 |
| US-10799610-B2 | Cement products and methods of making and using the same | BHMT2, SHMT1, BHMT | CCR2 3106/4885GABRR1 3616/4885CHRNB2 4525/4885 |
| US-10413632-B2 | Cement products and methods of making and using the same | BHMT2, SHMT1, BHMT | CCR2 3106/4885GABRR1 3616/4885CHRNB2 4525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.